MarkWide Research

Sale!

PCR and NGS Based Diagnostic Testing Market

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Industry trends

PCR and NGS Based Diagnostic Testing Market size exceeded USD 21.5 billion in 2020 and is estimated to grow at a CAGR of over -0.2% from 2021 to 2027. Rising importance of PCR & NGS based diagnostic testing in detection of viruses and other infectious diseases will accelerate the market growth.
 

PCR & NGS Based Diagnostic Testing Market Overview

Get more details on this report – Request Free Sample PDF
 

High risk of infection in geriatric population is one of the major factors responsible for the increased number of PCR & NGS based diagnostic testing. Growing usage of next generation sequencing techniques in the pharma and biopharma industry has boosted the sales of the equipment and consumables across the world. Additionally, increasing R&D activities in diagnostics industry in developed economies will creating growth opportunities for the PCR & NGS based diagnostic testing market.
 

PCR & NGS based diagnostic testing, as the name suggests are diagnostic tests based on technologies like polymerase chain reaction, and next generation sequencing. These tests are carried out to detect or confirm a presence of disease and to monitor its progression. PCR & NGS based diagnostic tests also include the use of diagnostic tools and equipment to analyse the samples and get accurate results. The advancement in technology over the years have aided in developing novel tests to determine the new or rare disease conditions.
 

Many companies and institutions are constantly involved in developing the advanced PCR and NGS technologies and improving the existing technologies for better disease diagnosis. The COVID-19 pandemic has impacted the PCR & NGS based diagnostic testing market positively. There has been tremendous rise in the number of PCR based tests for the detection of COVID-19. The demand for detection kits and consumables has surged all across the world. To cater to the demand, top companies like Thermo Fisher Scientific have increased their production for PCR based detection kits, and number of new companies have entered the market to manufacture diagnostic consumables. On the other hand, high cost of PCR & NGS based diagnostic testing can be a major factor hindering the industry growth

 

Rising importance of PCR & NGS based diagnostic tests for virus detection will propel the product demand

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was detected causing COVID-19. It was first originated in Wuhan, China. But soon it spread across the world and was officially declared as pandemic. The effect of COVID-19 is immensely catastrophic and pushing the healthcare system of even the developed markets such as the U.S. and Italy to the brink of collapse. Detection kits are considered as one of the key factors for tackling the spread of COVID-19 across the globe. Various research institutes and universities are adopting advanced technologies to develop advance testing kits. Medical device manufacturers have surged the development and production of COVID-19 detection kits, thus fostering the PCR & NGS based diagnostic testing market expansion.
 

Several companies are using their technologies and racing against time to develop PCR & NGS based diagnostic testing kits for faster detection of COVID-19 cases. GenMarkDx used its eSensor technology to minimize the risk of sample contamination. Recently, the company received Emergency Use Authorization (EUA) from FDA for its novel coronavirus diagnostic test ePlex SARS-CoV-2. XCR Diagnostics, a U.S. based startup offered their patented technology Xtreme Chain Reaction in point of care solutions. The increased importance of PCR & NGS based diagnostic testing and its high usage for virus detection during the pandemic will impel the PCR and NGS based diagnostic testing market demand.
 

Increasing usage of consumables in PCR & NGS based diagnostic testing will result in the market progression

The consumables segment in the PCR & NGS based diagnostic testing market accounted for USD 18.8 billion in 2020. Consumable segment includes the disposable products that are used in the PCR & NGS based diagnostic testing. This includes diagnostic kits (inclusive of COVID-19 detection kits), reagents, tips, plates, plastic cases etc. As these products are non-reusable, there is repetitive requirement of consumables in diagnostic tests. High demand and usage of consumables products is the prominent reason for its high industry size.
 

Growing number of diagnostic centers will offer significant market revenue opportunities

PCR & NGS Based Diagnostic Testing Market Size

Get more details on this report – Request Free Sample PDF
 

The diagnostic centers segment captured 36% of the PCR & NGS based diagnostic testing market share in 2020. The diagnostic centers are the special facilities with extensive variety of diagnostic testing procedures including PCR & NGS based diagnostic testing. Besides, the diagnostic centers have high testing capacity along with high accuracy due to advanced technology and apt medical infrastructure. All these factors are driving the segment growth for diagnostic centers in the short term. However, with reduction in COVID cases and tests, the market is expected to show negative growth by the end of the forecast period.
 

Increased number of diagnostic tests in North America region will accelerate the market value

North America PCR & NGS Based Diagnostic Testing Market

Get more details on this report – Request Free Sample PDF
 

The U.S. dominated the North America PCR & NGS based diagnostic testing market and accounted for over USD 5.4 billion in 2020. Also, the North America market is projected to showcase 1.2% growth rate through 2027 owing to the rising sales of consumables such as test kits, sample collectors and equipment like thermal cyclers. There has been sudden rise in the number of diagnostic tests since the outbreak of a pandemic. Moreover, increase in the diagnostic centers, ambulatory settings and makeshift facilities during the pandemic has resulted in high demand for PCR & NGS based diagnostic testing equipment and consumable materials supporting the industry expansion. In addition, presence of major market players such as Qiagen, Agilent, and Thermo Fisher Scientific among others is aiding the growth of PCR and NGS based diagnostic testing market in the region.
 

Rising number of participants involved in developing novel NGS and PCR based diagnostic products are pushing the market growth

Some of the key companies functioning in the PCR & NGS based diagnostic testing market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Eppendorf AG, Fluotics, Hamilton Company, Illumina, Inc., Integra LifeScience Holdings Corporation, MGI Tech Co., Ltd, Mascon, Inc., Qiagen Inc, Roche Diagnostics, Thermo Fisher Scientific, Thomas Scientific (The Carlyle Group), and VWR International (Avantor, Inc.). These industry leaders have been undergoing strategic developments to sustain the market competition and capture sizable revenue share in the testing industry.
 

Some of the recent industry developments:

  • In April 2021, Illumina and Kartos Therapeutics announced a partnership to develop an NGS-based TP53 companion diagnostic. This partnership is aimed at expanding the diagnostic offerings in oncology.
     
  • In March 2020, Qiagen released QIAstat-Dx test kit to the United States as a first syndromic test for detection of SARS-CoV-2 coronavirus. This novel panel contains assays targeting two genes used to widely detect SARS-CoV-2. This strategy will enhance the overall revenue and brand image of the firm in the industry
     

The PCR & NGS based diagnostic testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016-2027 (USD Million)

  • Consumables
  • Equipment
  • Labware

Market, By End-use, 2016-2027 (USD Million)

  • Hospital and clinics
  • Diagnostic centers
  • Ambulatory settings
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
       

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data Sources

1.5.1    Secondary

1.5.1.1    Paid Sources

1.5.1.2    Unpaid Sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    PCR & NGS based Diagnostic testing industry 3600 synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Product trends

2.1.3    End-use trends

2.1.4    Regional trends

Chapter 3   PCR & NGS based Diagnostic Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising importance of diagnostic tests in virus detection

3.3.1.2    Growing usage of NGS technology by pharmaceutical and biopharmaceutical companies

3.3.1.3    Increasing research and developmental (R&D) activities in developed economies

3.3.1.4    High risk of infection in geriatric population

3.3.2    Industry pitfalls and challenges

3.3.2.1    High cost of diagnostic testing

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By end-use

3.5    COVID-19 impact analysis

3.5.1    Impact of COVID-19 on global PCR & NGS based diagnostic testing market

3.5.2    Impact of COVID-19 on industry value chain

3.5.2.1    Research and development

3.5.2.2    Manufacturing

3.5.2.3    Marketing

3.5.2.4    Supply

3.5.3    Impact of COVID-19 on industry competition

3.5.3.1    Strategy

3.5.3.2    Product portfolio

3.5.3.3    Business growth

3.6    Porter’s analysis

3.7    Competitive landscape, 2020

3.7.1    Company matrix analysis, 2020

3.7.2    Manufacturing scenario

3.7.2.1    List of equipment manufacturers in the U.S., Europe, and Asia

3.7.2.2    List of consumable manufacturers in the U.S., Europe, and Asia

3.8    Consumer dynamics: equipment purchase vs leasing

3.9    Supply chain analysis

3.10    PESTEL analysis

3.11    Technology roadmap and future trends

Chapter 4   PCR & NGS based Diagnostic Testing Market, By Product

4.1    Key segment trends

4.2    Consumables

4.2.1    Market size, by region, 2016 – 2027

4.3    Equipment

4.3.1    Market size, by region, 2016 – 2027

4.4    Labware

4.4.1    Market size, by region, 2016 – 2027

Chapter 5   PCR & NGS based Diagnostic Testing Market, By End-use

5.1    Key segment trends

5.2    Hospitals and clinics

5.2.1    Market size, by region, 2016 – 2027

5.3    Diagnostic centers

5.3.1    Market size, by region, 2016 – 2027

5.4    Ambulatory settings

5.4.1    Market size, by region, 2016 – 2027

5.5    Others

5.5.1    Market size, by region, 2016 – 2027

Chapter 6   PCR & NGS based Diagnostic Testing Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size, by country, 2016 – 2027

6.2.2    Market size, by product, 2016 – 2027

6.2.3    Market size, by end-use, 2016 – 2027

6.2.4    U.S.

6.2.4.1    Market size, by product, 2016 – 2027

6.2.4.2    Market size, by end-use, 2016 – 2027

6.2.5    Canada

6.2.5.1    Market size, by product, 2016 – 2027

6.2.5.2    Market size, by end-use, 2016 – 2027

6.3    Europe

6.3.1    Market size, by country, 2016 – 2027

6.3.2    Market size, by product, 2016 – 2027

6.3.3    Market size, by end-use, 2016 – 2027

6.3.4    UK

6.3.4.1    Market size, by product, 2016 – 2027

6.3.4.2    Market size, by end-use, 2016 – 2027

6.3.5    France

6.3.5.1    Market size, by product, 2016 – 2027

6.3.5.2    Market size, by end-use, 2016 – 2027

6.3.6    Germany

6.3.6.1    Market size, by product, 2016 – 2027

6.3.6.2    Market size, by end-use, 2016 – 2027

6.3.7    Italy

6.3.7.1    Market size, by product, 2016 – 2027

6.3.7.2    Market size, by end-use, 2016 – 2027

6.3.8    Spain

6.3.8.1    Market size, by product, 2016 – 2027

6.3.8.2    Market size, by end-use, 2016 – 2027

6.4    Asia Pacific

6.4.1    Market size, by country, 2016 – 2027

6.4.2    Market size, by product, 2016 – 2027

6.4.3    Market size, by end-use, 2016 – 2027

6.4.4    India

6.4.4.1    Market size, by product, 2016 – 2027

6.4.4.2    Market size, by end-use, 2016 – 2027

6.4.5    China

6.4.5.1    Market size, by product, 2016 – 2027

6.4.5.2    Market size, by end-use, 2016 – 2027

6.4.6    Japan

6.4.6.1    Market size, by product, 2016 – 2027

6.4.6.2    Market size, by end-use, 2016 – 2027

6.4.7    Australia

6.4.7.1    Market size, by product, 2016 – 2027

6.4.7.2    Market size, by end-use, 2016 – 2027

6.5    Latin America

6.5.1    Market size, by country, 2016 – 2027

6.5.2    Market size, by product, 2016 – 2027

6.5.3    Market size, by end-use, 2016 – 2027

6.5.4    Brazil

6.5.4.1    Market size, by product, 2016 – 2027

6.5.4.2    Market size, by end-use, 2016 – 2027

6.5.5    Mexico

6.5.5.1    Market size, by product, 2016 – 2027

6.5.5.2    Market size, by end-use, 2016 – 2027

6.6    MEA

6.6.1    Market size, by country, 2016 – 2027

6.6.2    Market size, by product, 2016 – 2027

6.6.3    Market size, by end-use, 2016 – 2027

6.6.4    Saudi Arabia

6.6.4.1    Market size, by product, 2016 – 2027

6.6.4.2    Market size, by end-use, 2016 – 2027

6.6.5    South Africa

6.6.5.1    Market size, by product, 2016 – 2027

6.6.5.2    Market size, by end-use, 2016 – 2027

Chapter 7   Company Profiles

7.1    Strategy dashboard, 2020

7.2    Agilent Technologies, Inc

7.2.1    Business Overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Bio-Rad Laboratories, Inc

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    SWOT analysis

7.4    Eppendorf AG

7.4.1    Business Overview

7.4.2    Financial data

7.4.3    Product Landscape

7.4.4    SWOT analysis

7.5    Fluotics

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    SWOT analysis

7.6    Hamilton Company

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Illumina, Inc

7.7.1    Business Overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    SWOT analysis

7.8    Integra LifeScience Holdings Corporation

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    MGI Tech Co , Ltd

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    SWOT analysis

7.10    Mascon, Inc.

7.10.1    Business Overview

7.10.2    Financial data

7.10.3    Product Landscape

7.10.4    SWOT analysis

7.11    Qiagen

7.11.1    Business Overview

7.11.2    Financial data

7.11.3    Product Landscape

7.11.4    Strategy outlook

7.11.5    SWOT analysis

7.12    Roche Diagnostics

7.12.1    Business Overview

7.12.2    Financial data

7.12.3    Product Landscape

7.12.4    Strategy outlook

7.12.5    SWOT analysis

7.13    Thermo Fisher Scientific

7.13.1    Business Overview

7.13.2    Financial data

7.13.3    Product Landscape

7.13.4    Strategy outlook

7.13.5    SWOT analysis

7.14    Thomas Scientific (The Carlyle Group)

7.14.1    Business Overview

7.14.2    Financial data

7.14.3    Product Landscape

7.14.4    Strategy outlook

7.14.5    SWOT analysis

7.15    VWR International (Avantor, Inc.)

7.15.1    Business Overview

7.15.2    Financial data

7.15.3    Product Landscape

7.15.4    Strategy outlook

7.15.5    SWOT analysis
 

Data Tables

TABLE 1    Diagnostic testing market, 2016 – 2020, (USD Million)

TABLE 2    Diagnostic testing market, 2021 – 2027, (USD Million)

TABLE 3    Global PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 4    Global PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 5    Global PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 6    Global PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 7    Global PCR & NGS based diagnostic testing market by region, 2016 – 2020 (USD Million)

TABLE 8    Global PCR & NGS based diagnostic testing market by region, 2021 – 2027 (USD Million)

TABLE 9    Industry impact forces

TABLE 10    List of equipment manufacturers in US, Europe, and Asia

TABLE 11    List of consumable manufacturers in US, Europe, and Asia

TABLE 12    Consumables market by region, 2016 – 2020 (USD Million)

TABLE 13    Consumables market by region, 2021 – 2027 (USD Million)

TABLE 14    Equipment market by region, 2016 – 2020 (USD Million)

TABLE 15    Equipment market by region, 2021 – 2027 (USD Million)

TABLE 16    labware market by region, 2016 – 2020 (USD Million)

TABLE 17    Labware market by region, 2021 – 2027 (USD Million)

TABLE 18    Hospitals and clinics market by region, 2016 – 2020 (USD Million)

TABLE 19    Hospitals and clinics market by region, 2021 – 2027 (USD Million)

TABLE 20    Diagnostic centers market by region, 2016 – 2020 (USD Million)

TABLE 21    Diagnostic centers market by region, 2021 – 2027 (USD Million)

TABLE 22    Ambulatory settings market by region, 2016 – 2020 (USD Million)

TABLE 23    Ambulatory settings market by region, 2021 – 2027 (USD Million)

TABLE 24    Others market by region, 2016 – 2020 (USD Million)

TABLE 25    Others market by region, 2021 – 2027 (USD Million)

TABLE 26    North America PCR & NGS based diagnostic testing market, by country, 2016 – 2020, (USD Million)

TABLE 27    North America PCR & NGS based diagnostic testing market, by country, 2021 – 2027 (USD Million)

TABLE 28    North America PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 29    North America PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 30    North America PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 31    North America PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 32    U.S. PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 33    U.S. PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 34    U.S. PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 35    U.S. PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 36    Canada PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 37    Canada PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 38    Canada PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 39    Canada PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 40    Europe PCR & NGS based diagnostic testing market, by country, 2016 – 2020, (USD Million)

TABLE 41    Europe PCR & NGS based diagnostic testing market, by country, 2021 – 2027 (USD Million)

TABLE 42    Europe PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 43    Europe PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 44    Europe PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 45    Europe PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 46    UK PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 47    UK PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 48    UK PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 49    UK PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 50    France PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 51    France PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 52    France PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 53    France PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 54    Germany PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 55    Germany PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 56    Germany PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 57    Germany PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 58    Italy PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 59    Italy PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 60    Italy PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 61    Italy PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 62    Spain PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 63    Spain PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 64    Spain PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 65    Spain PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 66    Asia Pacific PCR & NGS based diagnostic testing market, by country, 2016 – 2020, (USD Million)

TABLE 67    Asia Pacific PCR & NGS based diagnostic testing market, by country, 2021 – 2027 (USD Million)

TABLE 68    Asia Pacific PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 69    Asia Pacific PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 70    Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 71    Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 72    India PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 73    India PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 74    India PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 75    India PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 76    China PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 77    China PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 78    China PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 79    China PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 80    Japan PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 81    Japan PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 82    Japan PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 83    Japan PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 84    Australia PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 85    Australia PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 86    Australia PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 87    Australia PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 88    Latin America PCR & NGS based diagnostic testing market, by country, 2016 – 2020, (USD Million)

TABLE 89    Latin America PCR & NGS based diagnostic testing market, by country, 2021 – 2027 USD Million)

TABLE 90    Latin America PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 91    Latin America PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 92    Latin America PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 93    Latin America PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 94    Brazil PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 95    Brazil PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 96    Brazil PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 97    Brazil PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 98    Mexico  PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 99    Mexico PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 100    Mexico  PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 101    Mexico  PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 102    MEA PCR & NGS based diagnostic testing market, by country, 2016 – 2020, (USD Million)

TABLE 103    MEA PCR & NGS based diagnostic testing market, by country, 2021 – 2027 (USD Million)

TABLE 104    MEA PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 105    MEA PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 106    MEA PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 107    MEA PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 108    Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 109    Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 110    Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 111    Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)

TABLE 112    South Africa PCR & NGS based diagnostic testing market, by product, 2016 – 2020, (USD Million)

TABLE 113    South Africa PCR & NGS based diagnostic testing market, by product, 2021 – 2027 (USD Million)

TABLE 114    South Africa PCR & NGS based diagnostic testing market, by end-use, 2016 – 2020, (USD Million)

TABLE 115    South Africa PCR & NGS based diagnostic testing market, by end-use, 2021 – 2027 (USD Million)
 

Charts & Figures

FIG. 1    Top-down approach

FIG. 2    COVID-19 detection kits data analysis approach

FIG. 3    Data validation

FIG. 4    PCR & NGS based Diagnostic testing industry 3600 synopsis, 2016 – 2027

FIG. 5    Industry segmentation

FIG. 6    Global PCR & NGS based diagnostic testing market, 2016 – 2027 (USD million)

FIG. 7    Growth potential analysis, by product

FIG. 8    Growth potential analysis, by end-use

FIG. 9    Impact of COVID-19 on PCR & NGS based diagnostic testing market, 2020-2022

FIG. 10  Impact of COVID-19 on industry value chain

FIG. 11  Impact of COVID-19 on industry competition

FIG. 12  Porter’s analysis

FIG. 13  Company matrix analysis, 2020

FIG. 14  Supply chain analysis

FIG. 15  PESTLE analysis

FIG. 16  Key segment trends, by product

FIG. 17  Key segment trends, by end-use

FIG. 18  Key regional trends

FIG. 19  Strategy dashboard, 2020
 

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF